
© DEA / ReutersEcstasy pills.
The world's first ever clinical trials of MDMA-assisted therapy for the treatment of alcohol dependency have begun at Imperial College London.
The study, led by researchers at the university, consists of various therapy sessions. The third of six weekly sessions will see participants taking MDMA, commonly known as the recreational drug ecstasy. It's hoped the study will provide alternative therapies for mental health conditions.
Dr Ben Sessa, a senior research fellow at Imperial who is working on the trials,
told TalkingDrugs that, with available treatments,
some 90 percent of alcoholics relapse at some point within four years, according to the National Institute for Alcohol Abuse and Alcoholism.
"Imagine those kind of outcomes in surgery or immunology or even oncology," Sessa, an experienced child psychologist, told TalkingDrugs. "Doctors wouldn't tolerate that. After 100 years of modern psychiatry, it's outrageous. If we can do any better than 90 percent relapse rates, then we're onto something."
Comment: The potential for probiotic treatments for addressing a number of health issues is really just in its infancy. As the science on the gut biome continues to progress, it's quite likely that we will evolve beyond our current methods of conferring immunity. It is also likely, however, that the Big Pharma cartel will hold on as tightly as it can to the current money-making paradigm, stooping to new lows in smears and attacks to maintain the status quo.
See also: